Shu-Hsiang Yang

Title: The Innovations of Shu-Hsiang Yang

Introduction

Shu-Hsiang Yang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for porcine diseases. His work has implications for the health and productivity of swine, which is crucial for the agricultural industry.

Latest Patents

Shu-Hsiang Yang holds a patent for a porcine circovirus type-2 (PCV2) subunit vaccine. This immunogenic composition includes an antigenic peptide that is a non-arginine-rich peptide derived from the PCV2 open reading frame 2 (ORF2). The innovative aspect of this vaccine lies in its formulation, which includes a recombinant fusion protein that combines the non-arginine-rich peptide with a PE peptide and a KDEL signal peptide. The design ensures that the number of arginines in the non-arginine-rich peptide does not exceed half of those in the arginine-rich domain of the N terminal of the PCV2 ORF2. This patent represents a significant advancement in vaccine technology for swine.

Career Highlights

Shu-Hsiang Yang is associated with Sbc Virbac Limited, where he continues to work on innovative solutions for animal health. His expertise in immunology and vaccine development has positioned him as a key figure in his field. His contributions are vital for enhancing the health of livestock and improving agricultural practices.

Collaborations

Shu-Hsiang Yang has collaborated with notable colleagues such as Tsun-Yung Kuo and Hsu-Chung Gabriel Chen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of veterinary medicine.

Conclusion

Shu-Hsiang Yang's work exemplifies the importance of innovation in veterinary science. His patent for the PCV2 subunit vaccine is a testament to his commitment to improving animal health and productivity. Through his career and collaborations, he continues to make a significant impact in the field.